CN

About Us
nanochap

Company Profile

Founded in 2014, Nanochap is a technology company specializing in the R&D, manufacturing, and commercialization of brain-computer interfaces (BCIs) and biochips. Nanochap is among the earliest companies in China dedicated to the development of visual BCI technologies.

Focused on restoring vision for people with blindness, Nanochap has pioneered a dual-pathway strategy for high-resolution artificial vision: E-BCI, an electronic retinal implant, and V-BCI, an implant targeting the visual cortex. Together, these complementary technologies aim to address a broad range of vision-loss conditions. The maximum number of signal acquisition and stimulation channels has reached 1,280, with core performance metrics ranking among the most advanced in the field and positioning Nanochap at the forefront of global visual restoration technology.

Nanochap has successfully established a full-stack technology platform spanning from core integrated circuits to system-level algorithms, achieving breakthroughs in a range of critical technologies, including high-density 3D electrodes, high-throughput BCI chips, ultra-precision MEMS processes, dynamic parameter control, and charge-balancing technologies. These capabilities form a robust technological foundation and create a strong competitive advantage in core technologies.

Backed by strong R&D capabilities, Nanochap has earned recognition as a National-Level “Little Giant” Enterprise and a National High-Tech Enterprise, and has been selected as a Zhejiang Provincial Leading Innovation and Entrepreneurship Team.

Milestones

2026

Secured Series C financing

Achieved a major clinical milestone as China’s first high-resolution visual BCI GCP clinical trial reached a successful outcome

Received the Ophthalmic Innovative Device Award at Global Ophthalmology Conference 2026

2026

Secured Series C financing

Achieved a major clinical milestone as China’s first high-resolution visual BCI GCP clinical trial reached a successful outcome

Received the Ophthalmic Innovative Device Award at Global Ophthalmology Conference 2026

2025

Became a founding member of the Brain-Computer Interface Subcommittee of China National Information Technology Standardization Committee

Selected for Zhejiang Provincial “Jianbing” R&D Program

Received the Technology Innovation Award at Global Ophthalmology Conference 2025

2025

Became a founding member of the Brain-Computer Interface Subcommittee of China National Information Technology Standardization Committee

Selected for Zhejiang Provincial “Jianbing” R&D Program

Received the Technology Innovation Award at Global Ophthalmology Conference 2025

2024

Established an overseas research center

Secured Series B+ financing

Recognized as a National-Level “Little Giant” Enterprise

2024

Established an overseas research center

Secured Series B+ financing

Recognized as a National-Level “Little Giant” Enterprise

2023

Selected as the Zhejiang Provincial High-Tech Enterprise R&D Center

Recognized as a Zhejiang Provincial Specialized and Sophisticated SME

2023

Selected as the Zhejiang Provincial High-Tech Enterprise R&D Center

Recognized as a Zhejiang Provincial Specialized and Sophisticated SME

2022

Obtained ISO 13485 certification

Recognized as a National High-Tech Enterprise

High-resolution visual BCI entered animal testing

2022

Obtained ISO 13485 certification

Recognized as a National High-Tech Enterprise

High-resolution visual BCI entered animal testing

2021

Secured Series B financing

Recognized as a Zhejiang International Science and Technology Cooperation Base

2021

Secured Series B financing

Recognized as a Zhejiang International Science and Technology Cooperation Base

2020

Achieved a breakthrough in wire-free chip-to-electrode bonding technology

Achieved a breakthrough in 3D electrode surface modification technology

Granted over 20 invention patents

2020

Achieved a breakthrough in wire-free chip-to-electrode bonding technology

Achieved a breakthrough in 3D electrode surface modification technology

Granted over 20 invention patents

2019

Selected for the Hangzhou Integrated Circuit Industry Development Project

Selected for a Yuhang District R&D Project in the Digital Economy Sector

Featured in the Most Promising Disruptive Innovation Ranking

2019

Selected for the Hangzhou Integrated Circuit Industry Development Project

Selected for a Yuhang District R&D Project in the Digital Economy Sector

Featured in the Most Promising Disruptive Innovation Ranking

2018

Secured Series A+ financing

Selected as one of the first batch of enterprises selected for the "Kunpeng Plan"

Recognized as an Outstanding Project of the Hangzhou "115" Overseas Talents Introduction Plan

Received the "Outstanding Hangzhou Entrepreneur" Award

Won the Upstyle Award for an innovative invention product

2018

Secured Series A+ financing

Selected as one of the first batch of enterprises selected for the "Kunpeng Plan"

Recognized as an Outstanding Project of the Hangzhou "115" Overseas Talents Introduction Plan

Received the "Outstanding Hangzhou Entrepreneur" Award

Won the Upstyle Award for an innovative invention product

2017

Led the National Key R&D Program of the 13th Five-Year Plan: Research and Development of Digital Diagnostic and Treatment Equipment

Selected as a Zhejiang Provincial Leading Innovation and Entrepreneurship Team

2017

Led the National Key R&D Program of the 13th Five-Year Plan: Research and Development of Digital Diagnostic and Treatment Equipment

Selected as a Zhejiang Provincial Leading Innovation and Entrepreneurship Team

2016

Secured Series A financing

Recognized as a Hangzhou High-Tech Enterprise

Listed on the Zhejiang International Innovation Talents Board

Designated as a key-supported enterprise of the Hangzhou Future Sci-Tech City (also known as Haichuangyuan)

2016

Secured Series A financing

Recognized as a Hangzhou High-Tech Enterprise

Listed on the Zhejiang International Innovation Talents Board

Designated as a key-supported enterprise of the Hangzhou Future Sci-Tech City (also known as Haichuangyuan)

2014

Company founded in February

Angel round financing completed in October

2014

Company founded in February

Angel round financing completed in October

Honors & Certifications

National-Level “Little Giant” Enterprise

Zhejiang Provincial High-Tech Enterprise R&D Center

Quality Management System for Medical Devices Certification

Headquarters:
Hangzhou, China

Address: 6th Floor, Building C, Betta Dream Works, 188 Lianchuang Street, Yuhang District, Hangzhou, China

Tel: +86 400-860-5922

Email: sales@nanochap.com

For Patients
BCI Technology BCI Products Biochips Neuromodulation System
News Press Release Media Report
About Us Company Profile Join Us Contact Us
FAQ Legal Notice Privacy Policy

© 2026 Nanochap Electronics Co., Ltd. All rights reserved Zhejiang ICP Preparation No. 16018040

Designed by：yushangweb